About the bill
- Full Title
A bill to eliminate requirements to undertake duplicative clinical testing of new pharmaceutical drugs, vaccines, biological products, or medical devices, when such duplication is inconsistent with relevant ethical norms.
The bill’s title was written by its sponsor.
Earlier Version — Introduced
This activity took place on a related bill, S. 3921 (111th).
This is the first step in the legislative process.
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
- Subject Areas
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2016). S. 3506 — 112th Congress: Ethical Pathway Act of 2012. Retrieved from https://www.govtrack.us/congress/bills/112/s3506
“S. 3506 — 112th Congress: Ethical Pathway Act of 2012.” www.GovTrack.us. 2012. June 30, 2016 <https://www.govtrack.us/congress/bills/112/s3506>
|title=S. 3506 (112th)
|accessdate=June 30, 2016
|author=112th Congress (2012)
|date=August 2, 2012
|quote=Ethical Pathway Act of 2012